Fabrication of docetaxel surfaced Fe 3O 4 magnetite nanoparticles and their cytotoxicity on 4T1 breast cancer cells

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Yazdi, Mh ^a   Najafi, Z Niazzadeh ^a   Khorramizadeh, Mr ^a   Amini, M ^b   Shahverdi, Ar ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

4T1 breast cancer cells; Antiproliferative effect; Docetaxel; Fe 3O 4 magnetite nanoparticles

Indexed keywords

DOCETAXEL; IRON OXIDE; IRON OXIDE MAGNETITE NANOPARTICLE; MAGNETITE NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; NANOMEDICINE; SYNTHESIS; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84868094680     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-15     Document Type: Article

References (16)

1. The side effects of chemotherapeutic agents. Carr C, Ng J, Wigmore T, Curr Anaesth Crit Care 2008 19 70 79 10.1016/j.cacc.2008.01.004 (Pubitemid 351437124)
2. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. Yoo HS, Park TG, J Control Release 2004 100 247 256 10.1016/j.jconrel.2004.08.017 15544872 (Pubitemid 39491276)
3. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Li X, Li R, Qian X, Ding Y, Tu Y, Guo R, Hu Y, Jiang X, Guo W, Liu B, Eur J Pharm Biopharm 2008 70 726 734 10.1016/j.ejpb.2008.06.016 18634874
4. Biodegradable dextran-based microspheres for delivery of anticancer drug mitomycin C. Cheung RY, Ying Y, Rauth AM, Marcon N, Wu XY, Biomaterials 2005 26 5375 5385 10.1016/j.biomaterials.2005.01.050 15814136 (Pubitemid 40462352)
5. Drug delivery with carbon nanotubes for in vivo cancer treatment. Liu Z, Chen K, Davis C, Sherlock S, Cao O, Chen X, Dai H, Cancer Res 2008 68 6652 6660 10.1158/0008-5472.CAN-08-1468 18701489
6. Liposomal delivery as a mechanism to enhance synergism between anticancer drugs. Lee RJ, Mol Cancer Ther 2006 5 1639 1640 10.1158/1535-7163.MCT-06-C02 16891448 (Pubitemid 44323230)
7. Dendrimers as drug carriers: applications in different routes of drug administration. Cheng Y, Xu Z, Ma M, Xu T, J Pharm Sci 2008 97 123 143 10.1002/jps.21079 17721949
8. Green synthesis of nanosilver particles from extract of eucalyptus hybrida (saeda) leaf. Dubey M, Bhadauria S, Kushwah BS, Dig J Nanomater Bios 2009 4 537 543
9. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Polyak B, Friedman G, Expert Opin. Drug Del 2009 6 53 70 10.1517/17425240802662795
10. Preparation of magnetite nanoparticles coated with an amphiphilic block copolymer: A potential drug. Bai Y, Teng B, Chen S, Chang Y, Li Z, Macromol. Rapid Commun 2006 27 2107 2112 10.1002/marc.200600504 (Pubitemid 46051871)
11. Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes. Dinauer N, Balthasar S, Weber C, Kreuter J, Langer K, von Briesen H, Biomaterials 2005 26 5898 5906 10.1016/j.biomaterials. 2005.02.038 15949555 (Pubitemid 40803459)
12. Umbelliprenin-coated Fe3O4 magnetite nanoparticles: Antiproliferation evaluation on human Fibrosarcoma cell line (HT-1080). Khorramizadeh MR, Esmail-Nazari Z, Zarei-Ghaane Z, Shakibaie M, Mollazadeh-Moghaddam K, Iranshahi M, Shahverdi AR, Mater Sci Eng C 2010 30 1038 1042 10.1016/j.msec.2010.05.005
13. Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells. Yvon AM, Wadsworth P, Jordan MA, Mol Biol Cell 1999 10 947 59 10198049 (Pubitemid 29193723)
14. Synthesis of magnetite (Fe3O4) nanoparticles without surfactants at room temperature. Martínez-Mera I, Espinosa-Pesqueira ME, Pérez- Hernández R, Arenas-Alatorre J, Mater Lett 2007 61 4447 4451 10.1016/j.matlet.2007.02.018 (Pubitemid 47304386)
15. Docetaxel immunonanocarriers as targeted delivery systems for HER2-positive tumor cells: preparation, characterization, and cytotoxicity studies. Noori Koopaei M, Dinarvand R, Amini M, Rabbani H, Emami S, Ostad SN, Atyabi F, Int J Nanomed 2011 6 1903 1912
16. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Saremi S, Atyabi F, Akhlaghi SP, Ostad SN, Dinarvand R, Int J Nanomed 2011 6 119 128